X

Rekvina Laboratories Ltd. Stock Analysis

Small Cap
Evaluated by 12 users | BSE: 526075 | NSE: |
Trading

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Capital Employed 0-5.09%-1.28%4.21%2.62%3.35%0.65%-10.41%-3.29%-12.59%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0000.10.10.100.100
Y-o-Y Gr. Rt.-NANANA0%0%-62.5%100%-100%NA
Adjusted EPS (Rs.) 0-0.05-0.010.030.030.040.01-0.09-0.03-0.13
Y-o-Y Gr. Rt.-NANANA0%33.3%-75%-1000%NANA
Book Value per Share (Rs.) 01.051.041.071.091.130.930.840.810.67
Adjusted Net Profit 0000000-0.10-0.1
Net Op. Cash Flow (Rs. Cr.) 0000000000
Debt to Cash Flow from Ops 000000-0.47-0.2316.87-8.94
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Rekvina Laboratories Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales NA-100%-100%NA
Adjusted EPS NA-234.1%-335.1%NA
Book Value per Share 0-9.3-10.4-17.3
Share Price - -11.5% -7.7% -17.4%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Equity (%) 0-5.1-1.282.52.63.340.64-10.62-3.89-17.92
Operating Profit Margin (%) 00038.6226.2435.915.4-89.9300
Net Profit Margin (%) 00019.5121.2128.8412.19-90.0700
Debt to Equity 0000000.020.020.350.51
Working Capital Days 0001,4531,6972,0045,0592,54900
Cash Conversion Cycle 000-6,422-67,2190-1,342-4,94000
Entity Percentage Holding
Promoters 41.30%
Non-Institutions 58.70%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Rekvina Labs's performance infers:

Rekvina Labs earnings have declined by -234.1%, whereas share price has depreciated -11.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback